First published on 21 January 2016.
Andrea Macdonald, founder of ideaXme, interviews Gitte Pedersen, co-founder and CEO of Genomic Expression.
Genomic Expression, a biotech startup which launched three months ago, brings a new diagnostic tool, OneRNA to the world. This test is set to change how oncologists prescribe cancer drugs and immunotherapy.
Latest News: Gitte Pederssen was shortlisted for Extreme Tech Challenge. She is in the process of scaling up her new company so that she can deliver the groundbreaking diagnostic test to people worldwide.
Covered:
The product
What is OneRNA?
Do all people respond to cancer drugs in the same way?
Why is there over diagnosis of cancer?
How will your test ensure that the prescribing of cancer drugs and immunotherapy is more targeted and effective?
Will your test have an impact on both the effectiveness of healthcare funding, as well as the treatments for cancer?
When and how can people receive access to this test?
Could you tell us about your Co-Founder and team?
Is your company for sale? If so, under what circumstances?
Your personal story.
What motivated you to embark on this mission?
What drives you?
Are you frightened of anything?
How was your childhood, time at school and university?
Mentoring
How do you contribute to Pipeline Angels?
Are more women leaders needed, if so, how can this be achieved?
What is your advice to young girls setting out on life?
Credits: Andrea Macdonald interview video, text, and audio
Follow ideaXme on Twitter: @ideaxm
On Instagram: @ideaxme
On YouTube: ideaxme
Find ideaXme across the internet including on iTunes, SoundCloud, Radio Public, TuneIn Radio, I Heart Radio, Google Podcasts, Spotify and more.
ideaXme is a global podcast, creator series and mentor programme. Our mission: Move the human story forward!™ ideaXme Ltd.
